Position in JNJ
as of Jun 30, 2026
· filed Jul 2, 2026
Position Value
$122,413
+$7,527 QoQ
Shares Held
482
+2.6% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.18%
of 13F equity value
Holder Rank
#4,561
of 4,676 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in JNJ Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Cedar Mountain Advisors, LLC holds $655,207 across 12 Drug Manufacturers - General names. JNJ ranks #3 (18.7% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | ABBV |
AbbVie Inc.
|
630 | $158,533 | |
| 2 | MRK |
Merck & Co., Inc.
|
1,215 | $156,127 | |
| 3 | JNJ |
Johnson & Johnson
This page
|
482 | $122,413 | |
| 4 | LLY |
ELI LILLY & Co
|
69 | $82,760 | |
| 5 | PFE |
Pfizer Inc
|
1,691 | $40,719 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
271 | $34,238 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
363 | $20,916 | |
| 8 | NVS |
Novartis AG
|
105 | $16,455 |
All Filings in JNJ
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $122,413 | 482 | Shares | Sole | 2026-07-02 | |
| 2026-03-31 | $114,886 | 470 | Shares | Sole | 2026-04-30 | |
| 2025-12-31 | $76,985 | 372 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $68,419 | 369 | Shares | Sole | 2025-10-24 | |
| 2025-06-30 | $35,132 | 230 | Shares | Sole | 2025-07-22 | |
| 2025-03-31 | $37,977 | 229 | Shares | Sole | 2025-04-14 | |
| 2024-12-31 | $32,973 | 228 | Shares | Sole | 2025-01-21 | |
| 2024-09-30 | $36,949 | 228 | Shares | Sole | 2024-10-15 | |
| 2024-06-30 | $33,178 | 227 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $35,750 | 226 | Shares | Sole | 2024-04-16 | |
| 2023-12-31 | $35,266 | 225 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $35,043 | 225 | Shares | Sole | 2023-10-23 | |
| 2023-06-30 | $37,076 | 224 | Shares | Sole | 2023-07-19 | |
| 2023-03-31 | $34,565 | 223 | Shares | Sole | 2023-04-11 | |
| 2022-12-31 | $37,096 | 210 | Shares | Sole | 2023-02-13 | |
| 2022-09-30 | $34,142 | 209 | Shares | Sole | 2022-10-11 | |
| 2022-06-30 | $36,922 | 208 | Shares | Sole | 2022-07-14 | |
| 2022-03-31 | $44,130 | 249 | Shares | Sole | 2022-04-14 | |
| 2021-12-31 | $42,425 | 248 | Shares | Sole | 2022-01-24 | |
| 2021-09-30 | $40,052 | 248 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $34,101 | 207 | Shares | Sole | 2021-07-15 | |
| 2021-03-31 | $69,355 | 422 | Shares | Sole | 2021-04-23 | |
| 2020-12-31 | $66,414 | 422 | Shares | Sole | 2021-01-28 | |
| 2020-09-30 | $62,827 | 422 | Shares | Sole | 2020-10-21 | |
| 2020-06-30 | $54,283 | 386 | Shares | Sole | 2020-07-20 | |
| 2020-03-31 | $50,485 | 385 | Shares | Sole | 2020-04-27 | |
| No filing history on record for this holder in this stock. | ||||||